Role of EMT in Metastasis and Therapy Resistance

Journal of Clinical Medicine
Bethany N Smith, Neil A Bhowmick

Abstract

Epithelial-mesenchymal transition (EMT) is a complex molecular program that regulates changes in cell morphology and function during embryogenesis and tissue development. EMT also contributes to tumor progression and metastasis. Cells undergoing EMT expand out of and degrade the surrounding microenvironment to subsequently migrate from the primary site. The mesenchymal phenotype observed in fibroblasts is specifically important based on the expression of smooth muscle actin (α-SMA), fibroblast growth factor (FGF), fibroblast-specific protein-1 (FSP1), and collagen to enhance EMT. Although EMT is not completely dependent on EMT regulators such as Snail, Twist, and Zeb-1/-2, analysis of upstream signaling (i.e., TGF-β, EGF, Wnt) is necessary to understand tumor EMT more comprehensively. Tumor epithelial-fibroblast interactions that regulate tumor progression have been identified during prostate cancer. The cellular crosstalk is significant because these events influence therapy response and patient outcome. This review addresses how canonical EMT signals originating from prostate cancer fibroblasts contribute to tumor metastasis and recurrence after therapy.

References

Jan 1, 1989·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·T P DawsonB Kaissling
Jul 1, 1995·The Journal of Cell Biology·F StrutzE G Neilson
Oct 1, 1993·Developmental Biology·V Garcia-Martinez, G C Schoenwolf
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·H YasudaT Suda
Dec 26, 2001·The Journal of Biological Chemistry·Takeshi UedaMarianne D Sadar
Jun 26, 2002·Kidney International·Maria P RastaldiGiuseppe D'Amico
Jul 5, 2003·Cancer Science·Setsuo Hirohashi, Yae Kanai
Jul 5, 2003·Physiological Reviews·Sabine Werner, Richard Grose
Oct 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John RinehartMark B Meyer
Sep 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lifang GaoDe-Qi Xu
Dec 13, 2005·Experimental Cell Research·Dongmin DangDaniel M Ramos
Jul 14, 2006·BMC Cancer·Kyle J HewittPatrice J Morin
Aug 8, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Sunfa ChengDavid H Lovett
Aug 23, 2006·Proceedings of the National Academy of Sciences of the United States of America·Kevin K KimHarold A Chapman
Oct 13, 2006·The Journal of Biological Chemistry·Jing HeJingwu Xie
Nov 18, 2006·Cell·Gaorav P Gupta, Joan Massagué
Feb 3, 2007·The Journal of Clinical Investigation·Christo D VenkovEric G Neilson
Jun 15, 2007·The Journal of Biological Chemistry·Michael ZeisbergRaghu Kalluri
Jul 31, 2007·Nature Medicine·Elisabeth M ZeisbergRaghu Kalluri
Feb 19, 2008·Cancer Research·David SarrióJosé Palacios
Apr 29, 2008·Nature Medicine·Greg FinakMorag Park
Sep 9, 2008·International Journal of Cancer. Journal International Du Cancer·Olivier De WeverMarc Bracke

❮ Previous
Next ❯

Citations

Mar 25, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xiao-Jun FengShu-Hui Zhang
Sep 10, 2016·Cell Communication and Signaling : CCS·Catharina MelzerRalf Hass
Sep 21, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hao WangYulan Ruan
Oct 18, 2016·Journal of Oncology·Chuang-Chi LiawYu-Hsiang Juan
Nov 3, 2016·Therapeutic Advances in Gastroenterology·Marina De RosaPaolo Delrio
May 12, 2017·Cell Death & Disease·Bylgja HilmarsdottirThorarinn Gudjonsson
Apr 20, 2017·Cancers·Benjamin Yaw OwusuLidija Klampfer
Apr 9, 2017·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Hendrik UngefrorenHendrik Lehnert
Jun 8, 2017·Molecular Oncology·Patricia G SantamariaAmparo Cano
Jun 28, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jianfa LiWeiren Huang
Jan 6, 2018·International Journal of Molecular Sciences·Sheng-Wei LaiChingju Lin
Jan 19, 2018·International Journal of Urology : Official Journal of the Japanese Urological Association·Diane BegemannNatasha Kyprianou
Aug 22, 2017·Nature Cell Biology·Simon GreletPhilip H Howe
Dec 2, 2017·Journal of Cellular and Molecular Medicine·Lei ChenZhi-Jun Sun
Sep 1, 2017·Journal of Cellular Biochemistry·Qiongyan ZouJia Yao
Dec 7, 2017·Journal of Applied Oral Science : Revista FOB·Camila Oliveira RodiniIan Campbell Mackenzie
Nov 13, 2018·Journal of Cellular Physiology·Mohammad Hossein Musavi ShenasMehdi Yousefi
Nov 28, 2018·Nature Reviews. Urology·Emma E van der ToomKenneth C Valkenburg
Jan 28, 2018·Nature Communications·Silvia Márquez-JuradoFrancisco J Iborra
May 18, 2016·SpringerPlus·Karolina Kowalska, Agnieszka Wanda Piastowska-Ciesielska
Aug 21, 2019·Molecular Omics·Virgínia Campos SilvestriniVítor Marcel Faça
Jul 12, 2017·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Kinan Drak Alsibai, Didier Meseure
Oct 17, 2019·Journal of Clinical Medicine·Miriam Teeuwssen, Riccardo Fodde
Dec 13, 2019·Cellular Oncology (Dordrecht)·Meysam YousefiSeyed H Ghaffari
Apr 24, 2019·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Lei ZouKun-Hua Wang

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
GTPases
surgical resection

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Cardiovascular Homeostasis

Cardiovascular regulation and homeostasis is important in maintaining health and dysfunction may lead to cardiovascular diseases. Nitric oxide and vascular endothelium are one of many molecules involved in the homeostatic mechanism. Here is the latest research on cardiovascular homeostasis.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Basement Membranes

Basement membranes are thin, specialized extracellular matrices surrounding most tissues in all metazoans. Here is the latest research on basement membranes.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.